暂无摘要。

Citrus greening (huanglonbing (HLB)) disease has drastically reduced citrus fruit production in Florida over the last two decades. Scientists have developed sustainable nutrient management practices to live with the disease and continue fruit production. Best pesticide management practices have been devised to reduce the spread of HLB by Asian citrus psyllid (ACP). However, soil application of excessive nutrients and the use of soil drench application of pesticides to huanglongbing-infected citrus groves have been a serious environmental concern since the recent development of resistance to some pesticides. It is important to understand the consequences of applying pesticides and nutrients beyond the recommended application rates with an inappropriate method for citrus growth and development. Alternatively, foliar sprays of some nutrients proved effective to meet plants\' requirements, and foliar sprays of effective insecticide products could provide an adequate mode of action for group rotation to minimize insecticide resistance by ACP and other pests. Sustainability in citrus production systems should include best management practices that improve pesticide and nutrient efficiency by including the total maximum daily load exiting the grove to reduce pesticide and nutrient exports into waterbodies.

According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance imidacloprid. To assess the occurrence of imidacloprid residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC, the MRLs established by the Codex Alimentarius Commission as well as the import tolerances and/or European authorisations reported by Member States (including the supporting residues data). Based on the assessment of the available data, MRL proposals were derived and a consumer risk assessment was carried out. Some information required by the regulatory framework was missing and a possible chronic/acute risk to consumers was identified. Hence, the consumer risk assessment is considered indicative only, some MRL proposals derived by EFSA still require further consideration by risk managers and measures for reduction of the consumer exposure should also be considered.

The EFSA was asked by the European Commission to perform an updated risk assessment of neonicotinoids, including imidacloprid, as regards the risk to bees, as a follow-up of previous mandates received from the European Commission on neonicotinoids. The context of the evaluation was that required by the European Commission in accordance with Article 21 of Regulation (EC) No 1107/2009 to review the approval of active substances in light of new scientific and technical knowledge and monitoring data. In this context and in accordance with Article 31 of Regulation (EC) No 178/2002, EFSA has been previously asked by the European Commission to organise an open call for data in order to collect new scientific information as regards the risk to bees from the neonicotinoid pesticide active substances clothianidin, thiamethoxam and imidacloprid applied as seed treatments and granules in the EU. The conclusions were reached on the basis of the evaluation of the supported uses as an insecticide of imidacloprid applied as seed treatments and granules, on the new relevant data collected in the framework of the open call organised by EFSA and on the updated literature search performed by EFSA. The reliable endpoints, appropriate for use in regulatory risk assessment derived from the submitted studies and literature data as well as any other relevant data available at national level and made available to EFSA, are presented. Concerns are identified.

Neonicotinoids are the most widely used insecticide class worldwide, and unfortunately, the widely used neonicotinoid imidacloprid is problematic for pollinators and other nontarget organisms. These nontarget impacts and the development of resistance prompt the ongoing development and testing of new neonicotinoids. The novel neonicotinoid cycloxaprid was described in 2011 and registered in China in 2015. Studies investigating its use and effect on target and nontarget species are recent and ongoing, and empirical evidence has not yet been collectively considered. Therefore, a systematic review was performed to identify and summarize data associated with target and nontarget, lethal and sublethal impacts of cycloxaprid for its use as a new insecticide. We performed keyword literature searches in Web of Science, PubMed, Academic Search Complete, and Google Scholar and explored citations used in identified articles. The search strategy yielded 66 citations; 25 citations fulfilled eligibility criteria and were included in the review. Under experimental conditions, cycloxaprid reduced populations of plant-feeding insect pests, suppressed populations of sucking and biting insect pests, and affected reproduction, development time, longevity, growth, gene regulation and expression, and phloem-feeding behavior of various life stages of certain insects. Studies focus on pest control efficacy and comparison with imidacloprid. Five nontarget organisms have been evaluated: Apis mellifera, Chrysoperla sinica, Harmonia axyridis, Daphnia magna, and Eisenia fetida. Variation in study design, to date, precludes a metaanalysis. However, these results provide valuable insight into possible effects to target and nontarget arthropods. Because cycloxaprid is a new insecticide, additional research is needed to clarify the mechanism of action of cycloxaprid and its metabolites, and to determine if it harms natural enemies or other nontarget organisms, if resistance develops, and if it exhibits cross-resistance with other insecticides. Although research on target arthropods will inform some effects on nontarget organisms, studies focusing explicitly on impacts to nontarget organisms are needed. Integr Environ Assess Manag 2020;16:831-840. © 2020 SETAC.

The large-scale use of neonicotinoid insecticides has raised growing concerns about their potential adverse effects on farmland birds, and more generally on biodiversity. Imidacloprid, the first neonicotinoid commercialized, has been identified as posing a risk for seed-eating birds when it is used as seed treatment of some crops since the consumption of a few dressed seeds could cause mortality. But evidence of direct effects in the field is lacking. Here, we reviewed the 103 wildlife mortality incidents reported by the French SAGIR Network from 1995 to 2014, for which toxicological analyses detected imidacloprid residues. One hundred and one incidents totalling at least 734 dead animals were consistent with an agricultural use as seed treatment. Grey partridges (Perdix perdix) and \"pigeons\" (Columba palumbus, Columba livia and Columba oenas) were the main species found. More than 70% of incidents occurred during autumn cereal sowings. Furthermore, since there is no biomarker for diagnosing neonicotinoid poisonings, we developed a diagnostic approach to estimate the degree of certainty that these mortalities were due to imidacloprid poisoning. By this way, the probability that mortality was due to poisoning by imidacloprid-treated seeds was ranked as at least \"likely\" in 70% of incidents. As a result, this work provides clear evidence to risk managers that lethal effects due to the consumption by birds of imidacloprid-treated seeds regularly occur in the field. This in turn raises the question of the effectiveness of the two main factors (seed burying and imidacloprid-treated seeds avoidance) that are supposed to make the risk to birds negligible. Risk factors and the relevance of mitigation measures are discussed.

A comprehensive review of published and previously unpublished studies was performed to evaluate the neonicotinoid insecticides for evidence of developmental neurotoxicity (DNT). These insecticides have favorable safety profiles, due to their preferential affinity for nicotinic receptor (nAChR) subtypes in insects, poor penetration of the mammalian blood-brain barrier, and low application rates. Nevertheless, examination of this issue is warranted, due to their insecticidal mode of action and potential exposure with agricultural and residential uses. This review identified in vitro, in vivo, and epidemiology studies in the literature and studies performed in rats in accordance with GLP standards and EPA guidelines with imidacloprid, acetamiprid, thiacloprid, clothianidin, thiamethoxam, and dinotefuran, which are all the neonicotinoids currently registered in major markets. For the guideline-based studies, treatment was administered via the diet or gavage to primiparous female rats at three dose levels, plus a vehicle control (≥20/dose level), from gestation day 0 or 6 to lactation day 21. F1 males and females were evaluated using measures of motor activity, acoustic startle response, cognition, brain morphometry, and neuropathology. The principal effects in F1 animals were associated with decreased body weight (delayed sexual maturation, decreased brain weight, and morphometric measurements) and acute toxicity (decreased activity during exposure) at high doses, without neuropathology or impaired cognition. No common effects were identified among the neonicotinoids that were consistent with DNT or the neurodevelopmental effects associated with nicotine. Findings at high doses were associated with evidence of systemic toxicity, which indicates that these insecticides do not selectively affect the developing nervous system.

Developed to replace organophosphate and carbamate insecticides, neonicotinoids are structurally similar to nicotine. The three main neonicotinoid insecticides, imidacloprid, clothianidin, and thiamethoxam, are being re-evaluated by Health Canada\'s Pest Management Regulatory Agency (PMRA). An important aspect of the re-evaluation is the potential for effects in non-target organisms, including aquatic organisms. Leaching into surface waters is one of the major concerns surrounding extensive use of neonicotinoids, especially in close proximity to water bodies. The PMRA has classified IMI as \'persistent\' with a \'high\' leaching potential. Globally, neonicotinoids have been detected in a variety of water bodies, typically at concentrations in the low μg/L range. While IMI has been included in some monitoring exercises, there are currently very few published data for the presence of CLO and THM in Canadian water bodies. The majority of neonicotinoid toxicity studies have been conducted with IMI due to its longer presence on the market and high prevalence of use. Aquatic insects are particularly vulnerable to neonicotinoids and chronic toxicity has been observed at concentrations of IMI below 1 μg/L. Acute toxicity has been reported at concentrations below 20 μg/L for the most sensitive species, including Hyalella azteca, ostracods, and Chironomus riparius. Fish, algae, amphibians, and molluscs are relatively insensitive to IMI. However, the biological effects of THM and CLO have not been as well explored. The Canadian interim water quality guideline for IMI is 0.23 μg/L, but there is currently insufficient use, fate, and toxicological information available to establish guidelines for CLO and THM. Based on concentrations of neonicotinoids reported in surface waters in Canada and globally, there is potential for aquatic invertebrates to be negatively impacted by neonicotinoids. Therefore, it is necessary to address knowledge gaps to inform decisions around guidelines and registration status for neonicotinoid insecticides in Canada to protect our aquatic ecosystems.